Evaluation of the application of national malaria treatment guidelines in private pharmacies in a rural area in the Democratic Republic of Congo

• Published in: Médecine et santé tropicales (Montrouge, France) Vol. 29; no. 4; p. 392
• Main Authors: Mandoko, P N, Mbongi, D M, Mumba, D N, Bi Shamamba, S K, Tshilolo, L M, Muyembe, J J, Parzy, D, Sinou, V
• Format: Journal Article
• Language: English; French
• Published: France 01.11.2019
• Subjects: rural area; Democratic Republic of the Congo; malaria; private pharmacies; artemisinin-based combination therapies
• DOI: 10.1684/mst.2019.0925

In the Democratic Republic of the Congo, the first recourse in case of suspected malaria in the health system is the private pharmacy sector. This study was therefore designed to assess private provider adherence to national case management guidelines in Kimpese, a rural area of Central Kongo province. A descriptive cross-sectional survey of 103 pharmacies took place in March 2016. The study included 97 pharmacies. The artemether-lumefantrine combination recommended as the first-line treatment for uncomplicated P. falciparum malaria was available in 100% of pharmacies but only 3% stocked quality-assured medicines. The sulfadoxine-pyrimethamine recommended for intermittent preventive treatment of malaria in pregnant women and quinine, which is no longer part of national policy, were widely available (>97.0% of pharmacies). Among providers, fewer than 20% were aware of the national malaria treatment guidelines. The main reasons for non-adherence to national guidelines among private dispensers was the high cost (up to 10 times more expensive than sulfadoxine-pyrimethamine treatment) and adverse effects of artemisinin-based combination therapies. Governmental interventions to improve private sector engagement in implementation of the national guidelines and to prevent the spread of ineffective and non-quality assured antimalarial medicines must be intensified.